ClearPoint Neuro, Inc.
CLPT
$10.00
-$0.40-3.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.22% | 31.04% | 36.34% | 29.33% | 24.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.22% | 31.04% | 36.34% | 29.33% | 24.86% |
| Cost of Revenue | 11.43% | 18.63% | 28.91% | 35.29% | 50.64% |
| Gross Profit | 32.08% | 40.46% | 41.69% | 25.62% | 10.63% |
| SG&A Expenses | 14.99% | 8.66% | 9.93% | 10.15% | 18.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.44% | 10.17% | 10.63% | 8.92% | 20.39% |
| Operating Income | -3.47% | 12.10% | 15.20% | 12.08% | -15.24% |
| Income Before Tax | -0.80% | 14.44% | 17.04% | 13.76% | -13.97% |
| Income Tax Expenses | 20.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.81% | 14.37% | 16.97% | 13.69% | -14.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.81% | 14.37% | 16.97% | 13.69% | -14.05% |
| EBIT | -3.47% | 12.10% | 15.20% | 12.08% | -15.24% |
| EBITDA | -3.11% | 14.07% | 17.64% | 14.56% | -12.95% |
| EPS Basic | 9.51% | 22.16% | 22.23% | 16.75% | -12.39% |
| Normalized Basic EPS | 9.50% | 22.22% | 22.30% | 16.83% | -12.31% |
| EPS Diluted | 9.51% | 22.16% | 22.23% | 16.75% | -12.39% |
| Normalized Diluted EPS | 9.50% | 22.22% | 22.30% | 16.83% | -12.31% |
| Average Basic Shares Outstanding | 11.16% | 9.84% | 6.90% | 4.03% | 1.71% |
| Average Diluted Shares Outstanding | 11.16% | 9.84% | 6.90% | 4.03% | 1.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |